News

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The FDA is phasing out animal testing for monoclonal antibody therapies, embracing AI and human-based models. Read more here.
Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...
Cruelty Free International welcomes major shift towards humane, modern approaches to drug development and testing ...
Human-Based Lab Models: The FDA will promote the use of lab-grown human “organoids” and organ-on-a-chip systems that mimic ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
A research team is developing a 3D-printed skin imitation equipped with living cells in order to test nanoparticles from cosmetics without animal testing.